New tuberculosis therapy offers potential shorter treatment. Phase III trials planned in Africa.
D000349:Africa; D017326:Clinical Trials, Phase III as Topic; D004334:Drug Administration Schedule; D024841:Fluoroquinolones / Q000008:administration & dosage*; D000077734:Gatifloxacin; D006801:Humans; D014376:Tuberculosis / Q000188:drug therapy*
D024841:Fluoroquinolones; D000077734:Gatifloxacin